跳至主要内容
临床试验/JPRN-jRCT2080223746
JPRN-jRCT2080223746已完成2 期

The clinical study to evaluate the efficacy, safety, and pharmacokinetics of MD-0901 in pediatric patients with mildly to moderately active ulcerative colitis.

MOCHIDA PHARMACEUTICAL CO., LTD0 个研究点目标入组 26 人开始时间: 2017年12月8日最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
26

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
ot applicable 至 <= 16age old(—)
性别
All

入选标准

  • (1)Subjects who are diagnosed as ulcerative colitis
  • (2)Subjects who are total score of 3-8 on the Ulcerative Colitis Disease Activity Index (UC-DAI) with a sigmoidoscopy score of 1 or higher, a rectal bleeding score of 1 or higher, and a Physician's Global Assessment (PGA) score of 2 or less at the baseline
  • (3)Body weight 18-90 kg at the baseline

排除标准

  • (1)Subjects with a history of colectomy (except appendectomy)
  • (2)Subjects with moderate/severe renal or liver impairment
  • (3)Subjects with serious blood disorder, respiratory disorder, digestive disorder, cardiovascular disorder, psychiatric disorder, abnormal electrolyte metabolism disorder or hypersensitivity as complication
  • (4)Subjects with malignant tumor as complication

研究者

发起方
MOCHIDA PHARMACEUTICAL CO., LTD

相似试验